Completed PHASE4 INTERVENTIONAL 2-arm NCT03935152

Oral Dydrogesterone in the Management of Preterm Labor

Oral Dydrogesterone as Adjunctive Therapy in the Management of Preterm Labor: A Randomized, Double Blinded, Placebo-controlled Trial

Sponsor: Chulalongkorn University

Conditions Preterm Labor

Interventions Dydrogesterone placebo

Updated 6 times since 2019 Last updated: Jan 20, 2021 Started: May 11, 2019 Primary completion: May 31, 2020 Completion: May 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Preterm Labor, this trial is completed. The trial is conducted by Chulalongkorn University and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Feb 2021 — Jul 2024 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jan 2021 — Feb 2021 [monthly]

Recruiting PHASE4
Aug 2019 — Jan 2021 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Jun 2019 — Aug 2019 [monthly]

Not Yet Recruiting PHASE4

First recorded

May 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chulalongkorn University

Data source: Chulalongkorn University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand